MedPath

Aerobic Exercise Training in Pulmonary Arterial Hypertension

Not Applicable
Completed
Conditions
Pulmonary Arterial Hypertension
Interventions
Other: Upper extremity aerobic exercise training
Other: Alternative upper extremity exercises
Registration Number
NCT02371733
Lead Sponsor
Gazi University
Brief Summary

Decreased exercise capacity, peripheral muscle strength and quality of life and increased dyspnea and fatigue perception is prevalent in patients with pulmonary arterial hypertension. It was demonstrated exercise training has beneficial effects in patients with pulmonary arterial hypertension. However, no study investigated the effects of upper extremity aerobic exercise training, therefore effects of upper extremity aerobic exercise training on outcomes in patients with pulmonary arterial hypertension.

Detailed Description

Patients were diagnosed with pulmonary arterial hypertension according to the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of f the European Society of Cardiology (ESC) and European Respiratory Society (ERS). Primary outcome measurement was exercise capacity, secondary outcomes were respiratory and peripheral muscle strength, physical activity, quality of life, fatigue, dyspnea and depression.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Clinically stable
  • Under standard medication
  • Group 1 pulmonary arterial hypertension patients
  • Having no exacerbation or infection
Exclusion Criteria
  • Cognitive disorders
  • Orthopedic and neurological problems
  • Pneumonia or acute infection
  • Stage 4 heart failure
  • Having no comorbidity to avoid performing evaluation and training

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Training GroupUpper extremity aerobic exercise trainingIntervention:Training group will receive upper extremity aerobic exercise training using arm ergometer and breathing exercises.
Control GroupAlternative upper extremity exercisesSham: Control group will receive alternative upper extremity exercises and breathing exercises.
Primary Outcome Measures
NameTimeMethod
Functional exercise capacity (Oxygen consumption measurement during test)6 weeks

Six minute walk test (6MWT)

Secondary Outcome Measures
NameTimeMethod
Maximum inspiratory and expiratory muscle strength (MIP, MEP)6 weeks

Mouth pressure device

Peripheral muscle strength6 weeks

Hand held dynamometer

Pulmonary functions6 week

Spirometry

Physical activity6 weeks

Activity monitor

Dyspnea6 weeks

Modified Borg and Modified Medical Research Council (MMRC) dyspnea scales

Fatigue6 weeks

Fatigue Severity Scale (FSS)

Generic quality of life6 weeks

Short Form (SF-36) Health Survey

Depression6 weeks

Montgomery Asberg Depression Rating Scale (MADRS) (Turkish versions of all scales)

Trial Locations

Locations (1)

Gazi University

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath